Moreover, significant changes in bone marrow plasma glucose and insulin levels and decreased bone formation marker osteocalcin and bone-specific ALP suggest HFD maternal obesity-related shifts in anabolic and catabolic responses that control bone homeostasis and explain postnatal bone phenotype characterized by μCT. The gene discussed is BGLAP; the disease is obesity disorder.